|
13.05.2015
More revenue, more jobs, more funding – all signs are pointing towards growth in the German biotech sector. These are the central conclusions of the company survey carried out by the information platform biotechnologie.de at the beginning of 2015 on behalf of the Federal Ministry of Education and Research (BMBF).
|
|
04.05.2015
More revenue, more staff, more funding: in the German biotech industry, all signs are pointing towards growth. These are the main results of the latest company survay of biotechnologie.de.
|
|
30.04.2014
2013 was something of a mixed year for the German biotech sector. Despite improved financing on the stock market, there was stagnation in turnover and employee numbers. This is confirmed by the results of the current survey of biotechnology companies that has biotechnologie.de carried out on behalf of the Federal Ministry of Education and Research earlier this year. Included is a separate survey of the research landscape for biotechnology.
|
|
16.05.2013
More turnover, more employees, more companies – the recent 2013 company survey by biotechnologie.de paints a picture of a biotechnology sector on a growth path.
|
|
04.03.2013
According to the latest ISAAA report, the global cultivation of genetically modified plants increased again in 2012. Spain tops the list in Europe.
|
|
10.05.2012
In 2011, the German biotechnology industry continued its moderate growth. . This is underlined by higher revenues of 2.6 billion euros (+10%), an increase in the number of employees to around 16,300 and a risen number of dedicated biotech firms (552). Facing a difficult financial situation - only a low sum of capital was invested in the sector - companies spent less money for research and development (R&D) and they have adapted their business models to the new conditions. These are the central findings of the company survey carried out at the beginning of 2012 by the information platform biotechnologie.de on behalf of the Federal Ministry of Education and Research (BMBF).
|
|
28.04.2011
Higher turnover, record financing and a growing number of employees - the German biotechnology sector is growing. These are the central results of the company survey carried out at the beginning of 2011 by the information platform biotechnologie.de on behalf of the Federal Ministry of Education and Research (BMBF).
|
|
23.04.2010
Unlike the majority of other industries, German biotechnology has actually grown during the crisis. In 2009, the number of employees exceeded the 30,000 mark for the first time. These are the central results of the company survey carried out at the beginning of 2010 by the information platform biotechnologie.de on behalf of the Federal Ministry of Education and Research (BMBF).
|
|
19.05.2008
In 2007, German biotechnology underwent distinctly moderate growth: For the first time, turnover climbed to over two billion euros (+14%), and expenditure on research and development (+8%) reached one billion euros – also a first.
|
|
24.10.2007
Every year, extensive surveys give us a wealth of facts and figures about the biotech sector in Germany: How has it developed? How much revenue have the companies generated? In this overview we have compiled the most interesting facts and figures to help you get to grips with the economic and financial situation of the core biotech companies in Germany.
|
